Cardiovascular alterations in rat fetuses exposed to calcium channel blockers

Reproductive Toxicology

Volumn 11, Issue 2-3, 1997, Pages 207-214

  Scott Jr , William J ^a,c   Resnick, Elisabeth ^a   Hummler, Hans ^b   Clozel, Jean Paul ^b   Bürgin, Heinrich ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

calcium channel blocker; cardiovascular alterations; diltiazem; maternal toxicity; nifedipine; verapamil

Indexed keywords

BENZIMIDAZOLE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; MIBEFRADIL; NIFEDIPINE; TETRALIN DERIVATIVE; VERAPAMIL;

ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA ARCH ANOMALY; ARTICLE; BLOOD PRESSURE; CALCIUM ANTAGONISM; CALCIUM CHANNEL; CARDIOVASCULAR MALFORMATION; COMPARATIVE STUDY; CONGENITAL MALFORMATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; FETOTOXICITY; FETUS; HEART DEVELOPMENT; IATROGENIC DISEASE; INCIDENCE; LEVOCARDIA; MALE; NONHUMAN; PREGNANCY; RAT; RAT STRAIN; STRUCTURE ANALYSIS; THORACIC AORTA;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; AORTA, THORACIC; BENZIMIDAZOLES; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DILTIAZEM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; LEVOCARDIA; MIBEFRADIL; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; TETRAHYDRONAPHTHALENES; VERAPAMIL;

ANIMALIA;

EID: 0342618780     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0890-6238(97)00008-7     Document Type: Article

References (21)

1. Murad F. Drugs used for the treatment of angina: organic nitrates, calcium channel blockers and β adrenergic antagonists. In Oilman A, Rail T, Nies A, Taylor P, eds. Goodman and Gilman's the pharmacological basis of therapeutics. New York: Pergamon Press; 1990:764-83.
2. Spedding M, Paoletti R. Classification of calcium channels and the sites of action of drugs modifying channel function. Pharmacol Rev. 1992;44:363-76.
3. Bacchus C, Kistler A. Unpublished observations. F. Hoffmann-La Roche, with permission.
4. Ariyuki F. Effects of diltiazem hydrochloride on embryonic development: species differences in the susceptibility and stage specificity in mice, rats, and rabbits. Okajimas Fol Anat Jpn. 1975;32:103-17.
5. Stein G, Srivastava M, Merker H-J, Neubert D. Effects of calcium channel blockers on the development of early rat postimplantation embryos in culture. Arch Toxicol. 1990;64:623-38.
6. Cabov A, Payka E. Some effects of Cordipin® (nifedipine) administered during pregnancy in the rats. Teratology. 1984;29:21A.
7. Spatz R, Pillalamori E, Diab G, Abadir A, Gintoutas J. Verapamil effect on fetus in rat. Proc West Pharmacol Soc. 1986;29:319-20.
8. Yoshida T, Kanamori S, Hasegawa Y. Hyperphalangeal bones induced in rat pups by maternal treatment with nifedipine. Toxicol Lett. 1988;40:127-32.
9. Danielsson BRG, Danielson M, Reiland S, et al. Histological and in vitro studies supporting decreased uteroplacental blood flow as explanation for digital defects after administration of vasodilators. Teratology. 1990;41:185-93.
10. Wilson JG. Embryological considerations in teratology. In Wilson JG, Warkany J, eds. Teratology, principles and techniques. Chicago: The University of Chicago Press; 1965:251-77.
11. Brockway B, Mills P, Azar J. A new method for continuous chronic measurement and recording of blood pressure, heart rate and activity in the rat via radio-telemetry. Clin Exp Hypertens. 1991;A13:885-95.
12. Teerlink JR, Clozel J. Hemodynamic variability and circadian rhythm in rats with heart failure: role of locomotor activity. Am J Physiol. 1993;264:H2111-H18.
13. Teerlink J, Löffler B-M, Hess P, Maire J-P, Clozel M, Clozel J-P. Role of endothelia in the maintenance of blood pressure in conscious rats with chronic heart failure. Circulation. 1994;90:2510-8.
14. Buelke-Sam J, Nelson CJ, Byrd RA, Holson JF. Blood flow during pregnancy in the rat: I. Flow patterns to maternal organs. Teratology. 1982;26:269-77.
15. Skandalakis J, Gray S, Symbas P. The thoracic and abdominal aorta. In Skandalakis J, Gray S, eds. Embryology for surgeons, 2nd ed. Baltimore: Williams and Wilkins; 1994:976-1030.
16. Newgreen D, Gooday D. Control of the onset of migration of neural crest cells in avian embryos. Cell Tissue Res. 1985;239:329-36.
17. Kirby M, Gale T, Stewart D. Neural crest cells contribute to normal aorticopulmonary septation. Science. 1983;220:1059-61.
18. Ferreira M, Hilfer R. Calcium regulation of neural fold formation: visualization of the actin cytoskeleton in living chick embryos. Dev Biol. 1993;159:427-40.
19. Danielsson B, Reiland S, Rundqvist E, Danielson M. Digital defects induced by vasodilating agents: relationship to reduction in uteroplacental blood flow. Teratology. 1989;40:351-8.
20. Kyselovic J, Leddy J, Ray A, Wigle J, Tuana B. Temporal differences in the induction of dihydropyridine receptor subunits and ryanodine receptors during skeletal muscle development. J Biol Chem. 1994;269:21770-7.
21. Magee LA, Schick B, Donnenfeld AE, Sage SR, Conover B, Cook L, McElhatton P, Schmidt MA, Koren G. The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study. Am J Obstet Gynecol. 1996;174:823-8.